Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term breast-cancer. Found 137 abstracts

no pagination
Packel L, Fang CY, Handorf E, Rodoletz M. A 12-Week Exercise and Stress Management Pilot Program From Theory Through Implementation and Assessment. Rehabilitation Oncology. 2017 Oct;35(4):172-80.
Zhang Y, Wang J, Xie J, Yang D, Han G, Zhang Y, Fu Q. The assay and clinical significance of serum thymidine kinase 1 in patients with colorectal carcinoma. Eur Surg. 2015 Oct;47(5):248-53.
Adams DL, Martin SS, Alpaugh RK, Charpentier M, Tsai S, Bergan RC, Ogden IM, Catalona W, Chumsri S, Tang CM, Cristofanilli M. Circulating giant macrophages as a potential biomarker of solid tumors. Proceedings of the National Academy of Sciences of the United States of America. 2014 Mar;111(9):3514-9.   PMCID: PMC 3948254
Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, Brockstein BE, Evens AM, Benjamin RS. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas(dagger). Annals of Oncology. 2013 Jan;24(1):257-63.   PMCID: not NIH funded
Rizzolio F, Caligiuri I, Lucchetti C, Fratamico R, Tomei V, Gallo G, Agelan A, Ferrari G, Toffoli G, Klein-Szanto AJ, Giordano A. Dissecting Pin1 and phospho-pRb regulation. Journal of cellular physiology. 2013 Jan;228(1):73-7.   PMCID: not NIH funded
Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Lustig R, Konski AA, Benson AB, Macdonald JS, Rich TA, Willett CG. FAILURE TO ADHERE TO PROTOCOL SPECIFIED RADIATION THERAPY GUIDELINES WAS ASSOCIATED WITH DECREASED SURVIVAL IN RTOG 9704-A PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR PATIENTS WITH RESECTED ADENOCARCINOMA OF THE PANCREAS. International Journal of Radiation Oncology Biology Physics. 2012 Feb;82(2):809-16.   PMCID: PMC133855
Alberts DS, Blessing JA, Landrum LM, Warshal DP, Martin LP, Rose SL, Bonebrake AJ, Ramondetta LM. Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study. Gynecologic Oncology. 2012 Dec;127(3):451-5.   PMCID: NIHMS342821
Betancourt AM, Wang J, Jenkins S, Mobley J, Russo J, Lamartiniere CA. Altered Carcinogenesis and Proteome in Mammary Glands of Rats after Prepubertal Exposures to the Hormonally Active Chemicals Bisphenol A and Genistein. Journal of Nutrition. 2012 Jul;142(7):1382S-1388S.   PMCID: PMC3374674
Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, Benitez J, Garcia MJ, Neuhausen S, Gail MH, Hartge P, Peock S, Frost D, Evans G, Eeles R, Godwin AK, Daly MB, Kwong A, Ma ES, Lazaro C, Blanco I, Montagna M, D'Andrea E, Nicoletto MO, Johnatty SE, Kruger S, Jensen A, Hogdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A, Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE, Senter L, Gore ME, Gourley C, Michie CO, Song HL, Tyrer J, Whittemore AS, McGuire V, Sieh W, Kristoffersson U, Olsson H, Borg A, Levine DA, Steele L, Beattie MS, Chan S, Nussbaum RL, Moysich KB, Gross J, Cass I, Walsh C, Li AJ, Leuchter R, Gordon O, Garcia-Closas M, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PD. Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer. JAMA-Journal of the American Medical Association. 2012 Jan;307(4):382-90.
Chen JQ, Russo J. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochimica Et Biophysica Acta-Reviews on Cancer. 2012 Dec;1826(2):370-84.   PMCID: not NIH funded
Chen XM, Cvetkovic D, Ma CM, Chen LL. Quantitative study of focused ultrasound enhanced doxorubicin delivery to prostate tumor in vivo with MRI guidance. Medical Physics. 2012 May;39(5):2780-6.
Chow HY, Jubb AM, Koch JN, Jaffer ZM, Stepanova D, Campbell DA, Duron SG, O'Farrell M, Cai KQ, Klein-Szanto AJ, Gutkind JS, Hoeflich KP, Chernoff J. p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model. Cancer Research. 2012 Nov;72(22):5966-75.   PMCID: PMC3500416
Coccia PF, Altman J, Bhatia S, Borinstein SC, Flynn J, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Orr KM, Pappo AS, Reed D, Spraker HL, Thomas DA, von Mehren M, Wechsler DS, Whelan KF, Zebrack BJ. Adolescent and Young Adult Oncology. Journal of the National Comprehensive Cancer Network. 2012 Sep;10(9):1112-50.   PMCID: Not NIH Funded
Fu J, Bassi DE, Zhang JR, Li TY, Nicolas E, Klein-Szanto AJ. Transgenic Overexpression of the Proprotein Convertase Furin Enhances Skin Tumor Growth. Neoplasia. 2012 Apr;14(4):271-82.   PMCID: PMC3349254
Gillet JP, Calcagno AM, Varma S, Davidson B, Elstrand MB, Ganapathi R, Kamat AA, Sood AK, Ambudkar SV, Seiden MV, Rueda BR, Gottesman MM. Multidrug Resistance-Linked Gene Signature Predicts Overall Survival of Patients with Primary Ovarian Serous Carcinoma. Clinical Cancer Research. 2012 Jun;18(11):3197-206.   PMCID: PMC3376649
Gorin A, Gabitova L, Astsaturov I. Regulation of cholesterol biosynthesis and cancer signaling. Current opinion in pharmacology. 2012 Dec;12(6):710-6.   PMCID: PMC 3504641
Konski A, Li TY, Christensen M, Cheng JD, Yu JQ, Crawford K, Haluszka O, Tokar J, Scott W, Meropol NJ, Cohen SJ, Maurer A, Freedman GM. Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in F-18-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer. Radiotherapy and Oncology. 2012 Jul;104(1):72-7.   PMCID: PMC3389132
Kozloff MF, Martin LP, Krzakowski M, Samuel TA, Rado TA, Arriola E, Carpeno JD, Herbst RS, Tarazi J, Kim S, Rosbrook B, Tortorici M, Olszanski AJ, Cohen RB. Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours. British Journal of Cancer. 2012 Oct;107(8):1277-85.   PMCID: PMC3494447
Lara H, Wang YH, Beltran AS, Juarez-Moreno K, Yuan XN, Kato S, Leisewitz AV, Fredes MC, Licea AF, Connolly DC, Huang L, Blancafort P. Targeting Serous Epithelial Ovarian Cancer with Designer Zinc Finger Transcription Factors. Journal of Biological Chemistry. 2012 Aug;287(35):29873-86.   PMCID: PMC3436144
Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Chubiz JE, Pisano ED, Gatsonis C, Ryan PD, Ozanne EM, Gazelle GS. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers. Cancer. 2012 Apr;118(8):2021-30.   PMCID: PMC3245774
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term breast-cancer

breast-cancer 1st-line therapy carcinoma paclitaxel expression therapy risk metastatic colorectal-cancer cell lung-cancer gene-expression positron-emission-tomography squamous-cell carcinoma cells endothelial growth-factor chemotherapy randomized controlled-trial pancreatic-cancer endocytosis plus radiotherapy c cisplatin drug-delivery liposomes trial molecular-cloning GOG Nab-paclitaxel-Cervix cancer-Drug resistant cervix cancer adjuvant radiotherapy local-control lymphoblastic-leukemia proliferation acute inducible thymidine kinase 1 non-hodgkins-lymphoma succinate-dehydrogenase in-vivo junction mek inhibitor pd0325901 intracellular trafficking protein expression 6-minute walk test adjuvant chemotherapy factor-i surveillance mutations receptor gemcitabine polymerase progression cost-effectiveness quality of life blood cell biomarkers raf kinase phase-ii microarray progenitors testicular-cancer growth film squamous-cell carcinomas prognosis akt fdg-pet marker Quality assurance rb sided definitive chemoradiotherapy united-states matrix-metalloproteinase formulation cancer 1984 orman ra-nature-v309-p467 cancer screening hospital volume brain in-utero exposure conditions mindfulness solid tumors rectal-cancer retinoblastoma susceptibility gene breast neoplasms lung-cancer esophagogastric expression profiles factor libraries nonsense lineage postoperative radiotherapy chemoradiation therapy long-term survivors product progesterone-receptor model Chemoradiotherapy pathway cell-cycle critical-appraisal degradation c-Myc p53-Glucose transporter-Glycolysis-TCA cycle-Glutaminolysis adriamycin fibroblast-growth-factor high familial risk plus bevacizumab human head cancer metastasis services task-force factors atfs ebp-delta prolyl 1991 kahashi ja-febs letters-v288-p65 uterine cervix identification megakaryocytes BRCA2 gene defects inhibitor golgi network isomerase pin1 quality-of-life BRCA1 gene mouse skin pak protein-kinases colorectal carcinoma mass screening cancer-cells childhood-cancer-survivor 1989 caprio ja-cell-v58-p1085 pathological response women collaborative british cohort soft-tissue sarcomas rats mouse model metaanalysis pentose-phosphate pathway survivorship pyruvate-dehydrogenase kinase perfusion in-vitro functional-characterization nuclear-localization biomarker susceptibility gene conditional expression functional assessment modulation 1991 llock bh-journal of pediatrics-v119-p725 1994 pov km-journal of biological chemistry-v269-p29720
Last updated on Friday, December 06, 2019